| In vivo–directed evolution of adeno-associated virus in the primate retina LC Byrne, TP Day, M Visel, JA Strazzeri, C Fortuny, D Dalkara, ... JCI insight 5 (10), e135112, 2020 | 98 | 2020 |
| Retinoschisin gene therapy in photoreceptors, Müller glia or all retinal cells in the Rs1h−/− mouse LC Byrne, BE Öztürk, T Lee, C Fortuny, M Visel, D Dalkara, DV Schaffer, ... Gene therapy 21 (6), 585-592, 2014 | 97 | 2014 |
| Visual stimulation switches the polarity of excitatory input to starburst amacrine cells AL Vlasits, R Bos, RD Morrie, C Fortuny, JG Flannery, MB Feller, ... Neuron 83 (5), 1172-1184, 2014 | 67 | 2014 |
| Neuron-glia signaling in developing retina mediated by neurotransmitter spillover JM Rosa, R Bos, GS Sack, C Fortuny, A Agarwal, DE Bergles, ... Elife 4, e09590, 2015 | 47 | 2015 |
| Mutation-independent gene therapies for rod-cone dystrophies C Fortuny, JG Flannery Retinal Degenerative Diseases: Mechanisms and Experimental Therapy, 75-81, 2018 | 14 | 2018 |
| AAV-mediated combination therapy of neurotrophic and anti-apoptotic factors in a mouse model of inherited retinal degeneration C Fortuny, L Byrne, D Dalkara, T Lee, BE Ozturk Investigative Ophthalmology & Visual Science 54 (15), 2746-2746, 2013 | 2 | 2013 |
| Self-inactivating vectors for gene editing K Baney, I Colin, C Fortuny, S Higgins, S Makhija, BT Staahl, A Maroof, ... US Patent App. 18/608,127, 2024 | | 2024 |
| AAV-Mediated Delivery of a Novel CasX-Editor Molecule Achieves Allele-Specific and Potent Editing of P23H Rhodopsin in a Mouse Model of Retinitis Pigmentosa C Fortuny, LE Fry, ME McClements, S Higgins, I Colin, A Castaneda, ... MOLECULAR THERAPY 32 (4), 98-98, 2024 | | 2024 |
| Aav vectors for gene editing M Mohr, K Baney, A Sidore, C Fortuny, A Maroof, A Wright, BT Staahl, ... US Patent App. 18/266,076, 2024 | | 2024 |
| Optimization of AAV Gene Delivery Vector Achieves Selective, Safe and Strong Muller Glia Targeting in Healthy and Diseased Rodent Retina C Fortuny, CK Baker, JG Flannery MOLECULAR THERAPY 28 (4), 484-485, 2020 | | 2020 |
| AAV-mediated Targeting of Müller Glia in Healthy and Diseased Retina C Fortuny, C Baker, JG Flannery Investigative Ophthalmology & Visual Science 60 (9), 2907-2907, 2019 | | 2019 |
| Development of Novel Adeno-Associated Virus-Mediated Gene Therapies for the Treatment of Inherited Retinal Degeneration C Fortuny UC Berkeley, 2019 | | 2019 |
| Optimization of AAV-mediated Gene Delivery for Targeting Mitochondria in the Outer Retina and Müller glia. EA Zin, C Fortuny, NP Sabetfakhri, RJ Choi, C Dunlap, J Flannery Investigative Ophthalmology & Visual Science 58 (8), 4090-4090, 2017 | | 2017 |
| Optimization of Mitochondrial AAV-Mediated Gene Delivery for Outer Retina and Glia C Fortuny, E Zin, C Dunlap, N Sabetfakhri, R Choi, JG Flannery MOLECULAR THERAPY 25 (5), 249-250, 2017 | | 2017 |
| Evaluation of CRB1 gene delivery in the rd8 mouse TP Day, C Fortuny, Y Oh, D Schaffer, JG Flannery Investigative Ophthalmology & Visual Science 57 (12), 1183-1183, 2016 | | 2016 |
| Expanding the Potential of AAV Vectors for the Treatment of Intractable Inherited Retinal Degenerations T Day, N Commins, C Fortuny, T Lee, J Flannery, D Schaffer MOLECULAR THERAPY 22, S45-S46, 2014 | | 2014 |
